Xiangjun Zeng

Prof. Xiangjun Zeng

School of Basic Medical Sciences, Capital Medical University, 100069,Beijing, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YLYu Liu
Yu Liu
JZJia Zhang
Jia Zhang
YWYangjia Wang
Yangjia Wang
XZXiangjun Zeng
Xiangjun Zeng
Podocyte autophagy dysfunction has been reported to be responsible for the progression of diabetic nephropathy (DN), however, the factors contributed to autophagy dysfunction in type 2 diabetes are not fully understood. Among promoting factors in DN, an adipokine, apelin, had been showed to trigger podocyte dysfunction. Therefore, it is hypothesized that apelin, which is increased in plasma in type 2 diabetes, lead to podocyte apoptosis through inhibiting podocyte autophagy, which resulted in podocyte dysfunction followed by DN. KkAy mice (diabetic mice) and cultured podocytes (MPC5 cells and native podocytes) were treated with high glucose (HG) and apelin or its antagonist F13A. Renal function, podocyte autophagy, podocyte apoptosis and corresponding cell signaling pathways in podocytes were detected. The results showed that apelin aggravated the renal dysfunction and foot process injuries in kkAy mice, which is positively correlated to podocyte apoptosis and negatively correlated to podocyte autophagy. Apelin induced podocyte apoptosis and inhibited podocyte autophagy in both normal glucose and HG conditions while F13A reversed these effects. Investigations by western blot found that apelin inhibits podocyte autophagy through ERK-, Akt- and mTOR-dependent pathways. In conclusion, increased apelin concentration in plasma inhibited podocyte autophagy, which would lead to podocyte apoptosis and renal dysfunction in diabetes. These effects would contribute to the progression of DN.

19 October 2013 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
BZBao-Hai Zhang
Bao-Hai Zhang
CGCai-Xia Guo
Cai-Xia Guo
HWHong-Xia Wang
Hong-Xia Wang
LLLing-Qiao Lu
Ling-Qiao Lu
YWYa-Jie Wang
Ya-Jie Wang
XZXiangjun Zeng
Xiangjun Zeng

23 June 2015 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CGCaixia Guo
Caixia Guo
YLYu Liu
Yu Liu
WZWenjie Zhao
Wenjie Zhao
SWShengnan Wei
Shengnan Wei
XZXiaoli Zhang
Xiaoli Zhang
XZXiangjun Zeng
Xiangjun Zeng
Podocyte injuries are associated with progression of diabetic nephropathy (DN). Apelin, an adipocyte‐derived peptide, has been reported to be a promoting factor for DN. In this study, we aim to determine whether apelin promotes progression of DN by inducing podocyte dysfunction. kk‐Ay mice were used as models for DN. Apelin and its antagonist, F13A were intraperitoneally administered for 4 weeks, respectively. Renal function and foot process proteins were analysed to evaluate the effects of apelin on kk‐Ay mice and podocytes. Apelin increased albuminuria and decreased podocyte foot process proteins expression in kk‐Ay mice, which is consistent with the results that apelin receptor (APLNR) levels increased in glomeruli of patients or mice with DN. In cultured podocytes, high glucose increased APLNR expression and apelin administration was associated with increased permeability and decreased foot process proteins levels. All these dysfunctions were associated with decreased 26S proteasome activities and increased polyubiquitinated proteins in both kk‐Ay mice and cultured podocytes, as demonstrated by 26S proteasome activation with cyclic adenosine monophosphate (cAMP) or oleuropein. These effects seemed to be related to endoplasmic reticulum (ER) stress, as apelin increased C/EBP homologous protein (CHOP) and peiFα levels while cAMP or oleuropein reduced it in high glucose and apelin treated podocytes. These results suggest that apelin induces podocyte dysfunction in DN through ER stress which was induced by decreased proteasome activities in podocytes.

5 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BZBao-Hai Zhang
Bao-Hai Zhang
WWWenying Wang
Wenying Wang
HWHongxia Wang
Hongxia Wang
JYJiming Yin
Jiming Yin
XZXiangjun Zeng
Xiangjun Zeng
Angiogenesis, increased glomerular permeability, and albuminuria are thought to contribute to the progression of diabetic nephropathy (DN). Apelin receptor (APLNR) and the endogenous ligand of APLNR, apelin, induce the sprouting of endothelial cells in an autocrine or paracrine manner, which may be one of the mechanisms of DN. The aim of this study was to investigate the role of apelin in the pathogenesis of DN. Therefore, we observed apelin/APLNR expression in kidneys from patients with type 2 diabetes as well as the correlation between albuminuria and serum apelin in patients with type 2 diabetes. We also measured the proliferating, migrating, and chemotactic effects of apelin on glomerular endothelial cells. To measure the permeability of apelin in glomerular endothelial cells, we used transwells to detect FITC-BSA penetration through monolayered glomerular endothelial cells. The results showed that serum apelin was significantly higher in the patients with type 2 diabetes compared to healthy people ( p <0.05, Fig. 1B ) and that urinary albumin was positively correlated with serum apelin (R = 0.78, p <0.05). Apelin enhanced the migration, proliferation, and chemotaxis of glomerular endothelial cells in a dose-dependent manner ( p <0.05). Apelin also promoted the permeability of glomerular endothelial cells ( p <0.05) and upregulated the expression of VEGFR2 and Tie2 in glomerular endothelial cells ( p <0.05). These results indicated that upregulated apelin in type 2 diabetes, which may be attributed to increased fat mass, promotes angiogenesis in glomeruli to form abnormal vessels and that enhanced apelin increases permeability via upregulating the expression of VEGFR2 and Tie2 in glomerular endothelial cells.

1 April 2021 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
BLBin Li
Bin Li
JYJiming Yin
Jiming Yin
JCJing Chang
Jing Chang
JZJia Zhang
Jia Zhang
YWYangjia Wang
Yangjia Wang
XZXiangjun Zeng
Xiangjun Zeng
Microcirculatory injuries had been reported to be involved in diabetic cardiomyopathy, which was mainly related to endothelial cell dysfunction. Apelin, an adipokine that is upregulated in diabetes mellitus, was reported to improve endothelial cell dysfunction and attenuate cardiac insufficiency induced by ischemia and reperfusion. Therefore, it is hypothesized that apelin might be involved in alleviating endothelial cell dysfunction and followed cardiomyopathy in diabetes mellitus. The results showed that apelin improved endothelial cell dysfunction via decreasing apoptosis and expression of adhesion molecules and increasing proliferation, angiogenesis, and expression of E-cadherin, VEGFR 2 and Tie-2 in endothelial cells, which resulted in the attenuation of the capillary permeability in cardiac tissues and following diabetic cardiomyopathy. Meanwhile, the results from endothelial cell-specific APJ knockout mice and cultured endothelial cells confirmed that the effects of apelin on endothelial cells were dependent on APJ and the downstream NFκB pathways. In conclusion, apelin might reduce microvascular dysfunction induced by diabetes mellitus via improving endothelial dysfunction dependent on APJ activated NFκB pathways.

9 October 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JYJiming Yin
Jiming Yin
YWYangjia Wang
Yangjia Wang
JCJing Chang
Jing Chang
BLBin Li
Bin Li
JZJia Zhang
Jia Zhang
XZXiangjun Zeng
Xiangjun Zeng
The epithelial−mesenchymal transition (EMT) of podocytes had been reported to be involved in the glomerular fibrosis in diabetic kidney diseases, which was regulated by TGFβ and NFκB pathways. And apelin, an adipokine which is upregulated in diabetic kidney diseases, was reported to be negatively correlated to TGFβ in polycystic kidney disease and attenuate EMT in renal tubular cells. Therefore, it is hypothesized that apelin might inhibit the EMT of podocytes through downregulating the expression and activation of TGFβ/Smad pathway in diabetic kidney diseases. The results showed that apelin in glomeruli of diabetic mice were increased and exogenous apelin inhibited the EMT of podocytes in diabetic mice, which were accompanied with the decreased expression of proteasome subunits β5i. The results from β5iKO mice confirmed that the inhibiting effects of apelin on EMT of podocytes in diabetic mice were dependent on β5i. The results from culture podocytes showed that apelin decreased the degradation of pIκB and promoted the translocation of IκB into nucleus through decreasing the expression of β5i, which would inhibit the promoting effects of NFκB on expression of TGFβ and followed by decreased activation of Smad pathway and EMT in podocytes. In conclusion, apelin might act as an EMT suppressor for podocytes to decrease the process of glomerular fibrosis in diabetic mice.